CC BY 4.0 · Surg J (N Y) 2018; 04(01): e46-e51
DOI: 10.1055/s-0038-1637000
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Recurrent 8-Year Ongoing Unilateral Breast Seroma Formation after PIP Implant Removal—A Case Report and Review of the Literature

Sonja Kästner
1   Center for Plastic and Aesthetic Surgery, Ocean Clinic Marbella, Marbella, Málaga, Spain
Felix Julian Paprottka
1   Center for Plastic and Aesthetic Surgery, Ocean Clinic Marbella, Marbella, Málaga, Spain
Phillipp Gonser
2   Department of Otolaryngology, Head and Neck Surgery, Eberhard Karls University Tuebingen, Tuebingen, Germany
Manuel De Villegas López
3   Center for Histopathology, Anatomía Patológica Marbella, Marbella, Spain
Kai Oliver Kaye
1   Center for Plastic and Aesthetic Surgery, Ocean Clinic Marbella, Marbella, Málaga, Spain
› Author Affiliations
Further Information

Publication History

27 October 2017

25 January 2018

Publication Date:
26 March 2018 (online)


Late seroma formation is a rare complication after implant-based breast enlargement surgery and even less frequent after implant removal. This case report presents a case of painful recurrent seroma formation after the removal of a ruptured Poly Implants Prothèse implant.

A 52-year-old patient presented herself in our clinic with a clinical history of recurrent unilateral seroma of the right breast over a period of 8 years after the initial unilateral implant removal. Removal of the remaining implant and complete bilateral capsulectomy was performed. Intraoperative findings revealed a macroscopically thickened capsule with signs of chronic inflammation on the affected side. The clinical history and the macroscopic appearance of the capsule demanded histopathological exclusion of a possible anaplastic large cell lymphoma.

Histopathological and microbiological analysis of the capsule and encapsulated material revealed no signs of malignancy or infection. Immediate soft tissue reconstruction of the breast was successfully performed using autologous fat transfer. An aesthetically satisfying result regarding symmetry and volume was achieved, and no further seroma formation was observed within a 6-month follow-up period.

Level of evidence: V, Case Report.

Presentation of This Work

05/2017: VDÄPC (German Aesthetic Surgery Meeting), Berlin, Germany

09/2017: DGPRÄC (German and Austrian Plastic Surgery Meeting), Graz, Austria

Financial Support and Industry Affiliations

There was no financial support of any kind contributing to this publication. No grants were accepted/used for this publication. None of the authors has any personal or institutional financial interest in the drugs, materials, or devices described in this submission.

Ethical Statement

The research project with all its procedures is in accordance with the national law and the World Medical Association Declaration of Helsinki (1964), with its ethical principles for medical research involving human subjects and subsequent amendments.

  • References

  • 1 Kjøller K, Hölmich LR, Jacobsen PH. , et al. Epidemiological investigation of local complications after cosmetic breast implant surgery in Denmark. Ann Plast Surg 2002; 48 (03) 229-237
  • 2 Nahabedian MY, Patel K. Management of common and uncommon problems after primary breast augmentation. Clin Plast Surg 2009; 36 (01) 127-138 , vii
  • 3 Bengtson B, Brody GS, Brown MH. , et al; Late Periprosthetic Fluid Collection after Breast Implant Working Group. Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature. Plast Reconstr Surg 2011; 128 (01) 1-7
  • 4 Heffner HE, Brown LK, Barbieri CA. ; Primary Study Investigators. Diagnostic value of tests that discriminate between exsudative and transudative pleural effusions. Chest 1997; 111 (04) 970-980
  • 5 Pinchuk V, Tymofii O. Seroma as a late complication after breast augmentation. Aesthetic Plast Surg 2011; 35 (03) 303-314
  • 6 Mazzocchi M, Dessy LA, Carlesimo B, Marchetti F, Scuderi N. Late seroma formation after breast surgery with textured silicone implants: a problem worth bearing in mind. Plast Reconstr Surg 2010; 125 (04) 176e-177e
  • 7 Hasham S, Akthar S, Fourie LR. Persistent seroma following breast prosthesis explantation: a case report and review. Eur J Plast Surg 2006; 28 (07) 490-493
  • 8 Park BY, Lee DH, Lim SY. , et al. Is late seroma a phenomenon related to textured implants? A report of rare complications and a literature review. Aesthetic Plast Surg 2014; 38 (01) 139-145
  • 9 Oliveira VM, Roveda Junior D, Lucas FB. , et al. Late seroma after breast augmentation with silicone prostheses: a case report. Breast J 2007; 13 (04) 421-423
  • 10 Lindsey WH, Masterson TM, Spotnitz WD, Wilhelm MC, Morgan RF. Seroma prevention using fibrin glue in a rat mastectomy model. Arch Surg 1990; 125 (03) 305-307
  • 11 Weathers WM, Wolfswinkel EM, Hatef DA, Lee EI, Hollier LH, Brown RH. Implant-associated anaplastic large cell lymphoma of the breast: Insight into a poorly understood disease. Can J Plast Surg 2013; 21 (02) 95-98
  • 12 Laurent C, Delas A, Gaulard P. , et al. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol 2016; 27 (02) 306-314
  • 13 Kim B, Roth C, Young VL. , et al. Anaplastic large cell lymphoma and breast implants: results from a structured expert consultation process. Plast Reconstr Surg 2011; 128 (03) 629-639
  • 14 Soo MS, Kornguth PJ, Georgiade GS, Sullivan DC. Seromas in residual fibrous capsules after explantation: mammographic and sonographic appearances. Radiology 1995; 194 (03) 863-866
  • 15 Pittman TA, Fan KL, Rudolph MA. Anaplastic large cell lymphoma: Emerging consent and management patterns among American and International Board Certified Plastic Surgeons. Plast Reconstr Surg 2016; 138 (05) 811e-818e
  • 16 Talagas M, Uguen A, Charles-Petillon F. , et al. Breast implant-associated anaplastic large-cell lymphoma can be a diagnostic challenge for pathologists. Acta Cytol 2014; 58 (01) 103-107
  • 17 Henry AS, Kerfant N, Blanc C, Trimaille A, Costa S, Hu W. [Anaplastic large cell lymphoma after breast prosthesis removal: about a case]. Ann Chir Plast Esthet 2015; 60 (01) 70-73
  • 18 Aladily TN, Medeiros LJ, Amin MB. , et al. Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol 2012; 36 (07) 1000-1008
  • 19 Wong AK, Lopategui J, Clancy S, Kulber D, Bose S. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature. Am J Surg Pathol 2008; 32 (08) 1265-1268
  • 20 Hu H, Jacombs A, Vickery K, Merten SL, Pennington DG, Deva AK. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg 2015; 135 (02) 319-329
  • 21 Brody GS, Deapen D, Taylor CR. , et al. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg 2015; 135 (03) 695-705
  • 22 Taylor CR, Siddiqi IN, Brody GS. Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases. Appl Immunohistochem Mol Morphol 2013; 21 (01) 13-20
  • 23 Allan JM, Jacombs AS, Hu H, Merten SL, Deva AK. Detection of bacterial biofilm in double capsule surrounding mammary implants: findings in human and porcine breast augmentation. Plast Reconstr Surg 2012; 129 (03) 578e-580e
  • 24 Kellogg BC, Hiro ME, Payne WG. Implant-associated anaplastic large cell lymphoma: beyond breast prostheses. Ann Plast Surg 2014; 73 (04) 461-464
  • 25 Quaba O, Quaba A. PIP silicone breast implants: rupture rates based on the explantation of 676 implants in a single surgeon series. J Plast Reconstr Aesthet Surg 2013; 66 (09) 1182-1187
  • 26 Chummun S, McLean NR. Poly implant prothèse (PIP) breast implants: our experience. Surgeon 2013; 11 (05) 241-245
  • 27 Fenoll C, Leclère FM, Hivelin M. , et al. [Poly Implant Prothèse (PIP®) incidence of complications in breast reconstructive surgery: a retrospective comparative analysis] [Article in French]. Ann Chir Plast Esthet 2015; 60 (06) 478-483
  • 28 SCENIHR. Scientific opinion on PIP silicone gel breast implants. 2014; . Accessed February 10, 2018
  • 29 Koutsomanis A, Bruant-Rodier C, Roedlich MN, Bretz-Grenier MF, Perrot P, Bodin F. [Radiological trap and oncological precautions in a patient who has undergone a permanent withdrawal of PIP breast implants] [Article in French]. Ann Chir Plast Esthet 2015; 60 (06) 533-536
  • 30 Vergine M, Ballesio L, Amabile MI. , et al. [Seroma in residual fibrous capsule after breast implant explantation: a case report] [Article in Italian]. G Chir 2008; 29 (04) 169-171
  • 31 Deva AK, Adams Jr WP, Vickery K. The role of bacterial biofilms in device-associated infection. Plast Reconstr Surg 2013; 132 (05) 1319-1328
  • 32 Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 2008; 21 (04) 455-463